A separate analysis of 127 people with HIV/HCV coinfection who received a 12-week course of ledipasvir/sofosbuvir (99 who achieved cure) evaluated the impact of HCV cure on serum IL-6 and soluble tumor necrosis factor receptor I [75]. Here, IL6 is linked to coinfection.